Browse Category

Stock Market News 27 December 2025

AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus

NEW YORK, Dec. 27, 2025, 5:15 PM ET — Market closed. AbbVie Inc. (NYSE: ABBV) heads into the weekend with Wall Street shut and year-end positioning in full swing, after a quiet, post-holiday session on Friday left major U.S. indexes essentially unchanged. In thin trading, investors continue to weigh two competing narratives: a strong 2025 for equities and the seasonally bullish “Santa Claus rally” window — versus the reality that year-end liquidity can amplify moves on any surprise headline. Reuters Where AbbVie stock stands heading into Monday’s sessionAbbVie’s last trade/close sits at $229.98, leaving the stock near the upper end
MercadoLibre Stock (MELI) Holds Near $2,006 as U.S. Markets Close for the Weekend—Latest News, Analyst Targets, and What to Watch Before Monday

MercadoLibre Stock (MELI) Holds Near $2,006 as U.S. Markets Close for the Weekend—Latest News, Analyst Targets, and What to Watch Before Monday

NEW YORK, Dec. 27, 2025, 5:20 p.m. ET — Market closed MercadoLibre, Inc. (Nasdaq: MELI) heads into the final stretch of the year with its stock hovering around the psychologically important $2,000 level after a quiet, holiday-thinned week on Wall Street. With U.S. equity markets closed Saturday and Sunday, investors now have a full weekend to digest the latest commentary on MercadoLibre’s valuation, competitive landscape, and 2026 setup—before liquidity returns when markets reopen Monday. Shares of MercadoLibre last closed at $2,005.71 (with after-hours trading little changed), leaving the stock near the midpoint of its recent range after a pullback from
Cisco Stock (CSCO) Holds Near $78 as Markets Close for the Weekend; Investors Parse New Channel Focus, Real-Estate Move, and 2026 Outlook

Cisco Stock (CSCO) Holds Near $78 as Markets Close for the Weekend; Investors Parse New Channel Focus, Real-Estate Move, and 2026 Outlook

NEW YORK, Dec. 27, 2025, 5:14 p.m. ET — Market closed. Cisco Systems, Inc. (NASDAQ: CSCO) heads into the weekend with shares hovering near the $78 level after a quiet, holiday-thinned stretch of trading that left many large-cap tech names range-bound. Cisco last closed at $78.16 on Friday, Dec. 26, in a session that saw relatively light year-end volume across U.S. equities. Nasdaq Cisco stock price: where CSCO left off before the weekend Cisco ended Friday modestly higher, with trading constrained to a narrow band as investors returned from the Christmas holiday and positioned for the final three sessions of
Kraft Heinz Stock (KHC) Weekend Update: Latest News, Analyst Forecasts, and What to Watch Before Monday’s Open

Kraft Heinz Stock (KHC) Weekend Update: Latest News, Analyst Forecasts, and What to Watch Before Monday’s Open

NEW YORK, Dec. 27, 2025, 5:15 p.m. ET — Market closed Kraft Heinz shares are heading into the final trading days of 2025 with investors still focused on one dominant catalyst: the packaged-food giant’s CEO transition and its planned breakup into two standalone public companies. U.S. stock markets are closed today for the weekend, so the most recent read on The Kraft Heinz Company (NASDAQ: KHC) is Friday’s close—when KHC finished around $24.13, up about 0.46% on the session. StockAnalysis That move came as Wall Street itself went into “catch your breath” mode in thin post-holiday trading. On Friday, the
Santa Claus Rally Watch: S&P 500 Near 7,000 as Fed Minutes Loom and Gold, Silver Smash Records

Santa Claus Rally Watch: S&P 500 Near 7,000 as Fed Minutes Loom and Gold, Silver Smash Records

Wall Street is closing out 2025 with a familiar year-end mix: record-level equity prices, thin holiday liquidity, and a growing list of “what could move markets next week” catalysts—from Federal Reserve minutes to political headlines around the next Fed chair. After a quiet post-Christmas session on Friday, December 26, U.S. stocks finished barely changed but still near all-time highs, keeping investors focused on whether the seasonal “Santa Claus rally” can carry major indexes into the final trading days of the year. Reuters+2Reuters+2 A muted Friday masks a powerful year-end run In the low-volume session on Dec. 26, the Dow Jones
Realty Income (O) Stock Update: Monthly Dividend REIT Faces Year-End Rates Test as Wall Street Eyes Next Session

Realty Income (O) Stock Update: Monthly Dividend REIT Faces Year-End Rates Test as Wall Street Eyes Next Session

NEW YORK, Dec. 27, 2025, 5:11 p.m. ET — Market closed Realty Income Corporation (NYSE: O) heads into the next U.S. trading session with investors weighing two familiar forces that often dominate “The Monthly Dividend Company®” narrative: interest-rate expectations and the durability of its dividend-growth track record. With U.S. equity markets closed for the weekend, Realty Income shares are effectively “parked” at their latest Friday levels—leaving investors to digest the latest analyst commentary and year-end market positioning before Monday’s open. Broader market conditions remain calm but data-light: Wall Street wrapped up Friday’s post-holiday session near record territory in thin trading,
Medical Properties Trust (MPW) Stock News: Wall Street Zen Downgrade, Analyst Targets, and What Investors Should Watch Before Monday’s Open

Medical Properties Trust (MPW) Stock News: Wall Street Zen Downgrade, Analyst Targets, and What Investors Should Watch Before Monday’s Open

NEW YORK, Dec. 27, 2025, 5:10 p.m. ET — Market closed Medical Properties Trust, Inc. (NYSE: MPW) heads into the final trading days of 2025 with its stock pinned near the mid-$5 range after a quiet, holiday-thinned week for U.S. equities — and after a fresh weekend analyst downgrade added a new headline for investors to weigh. MPW finished Friday’s session at $5.08 and was flat in extended trading shortly before the after-hours window ended. MarketBeat While broad U.S. indexes are hovering close to record territory, market strategists say the post-Christmas tape has been driven more by positioning and seasonality
Salesforce Stock News: CRM Holds Near $266 as AI Agentforce Momentum Meets New Reliability Questions

Salesforce Stock News: CRM Holds Near $266 as AI Agentforce Momentum Meets New Reliability Questions

NEW YORK, Dec. 27, 2025, 5:08 p.m. ET — Market Closed Salesforce, Inc. (NYSE: CRM) enters the final stretch of 2025 with investors weighing two competing narratives: accelerating monetization from its AI agent platform (Agentforce) and a fresh wave of headlines questioning how “ready” large language models (LLMs) are for mission-critical enterprise workflows. With U.S. stock markets closed for the weekend, Salesforce shares were last quoted around $266.08, up about 0.3% from the prior close, based on the latest available market data. StockAnalysis The next key test comes when trading resumes on Monday, Dec. 29, when investors will parse whether
GE Vernova Stock (NYSE: GEV) Holds Near $663 as AI Data-Center Power Demand Stays in Focus—What Investors Should Watch Before Markets Reopen

GE Vernova Stock (NYSE: GEV) Holds Near $663 as AI Data-Center Power Demand Stays in Focus—What Investors Should Watch Before Markets Reopen

NEW YORK, Dec. 27, 2025, 5:07 p.m. ET — Market closed New York Stock Exchange GE Vernova Inc. (NYSE: GEV) enters the final stretch of 2025 with investor attention split between a familiar year-end market backdrop—thin trading, near-record index levels—and a very specific catalyst that keeps popping up in the energy equipment complex: the urgent race to power AI data centers. With U.S. stock markets closed for the weekend, GE Vernova shares were last indicated around $663, reflecting Friday’s final prints after a quiet post-holiday session on Wall Street. Yahoo Finance+1 GE Vernova stock recap: where GEV left off on
Ares Capital Corporation (ARCC) Stock News: Dividend Payday Nears as Analysts See Upside After Thin Holiday Trade

Ares Capital Corporation (ARCC) Stock News: Dividend Payday Nears as Analysts See Upside After Thin Holiday Trade

NEW YORK, Dec. 27, 2025, 5:03 p.m. ET — Market Closed New York Stock Exchange Ares Capital Corporation (NASDAQ: ARCC) heads into the final full week of 2025 with investors focused on two near-term catalysts: a high-yield dividend payment scheduled for next week and a year-end tape shaped by thin liquidity and “Santa Claus rally” seasonality. With U.S. stock markets closed Saturday, ARCC’s latest read-through remains Friday’s session—when the business development company (BDC) finished higher even as major indexes slipped modestly in post-holiday trade. Nasdaq+1 ARCC stock price: where shares left off before the weekend ARCC ended Friday’s regular session
Cameco Stock (CCJ) Weekend Update: Unusual Options Activity, Uranium Price Backdrop, and Analyst Targets Ahead of Monday’s Open

Cameco Stock (CCJ) Weekend Update: Unusual Options Activity, Uranium Price Backdrop, and Analyst Targets Ahead of Monday’s Open

NEW YORK, Dec. 27, 2025, 5:02 p.m. ET — Market closed. Cameco Corporation (NYSE: CCJ; TSX: CCO) heads into the final trading week of the year with investors weighing a fresh burst of options activity and new institutional positioning against a supportive uranium price tape and the company’s longer-term nuclear-fuel demand thesis. With U.S. equities closed for the weekend, CCJ is effectively frozen at Friday’s closing levels until premarket trading resumes Monday. Cameco’s U.S.-listed shares last stood at $92.84, down $0.50 on the session, while the company’s Toronto-listed shares were shown at C$127.48. Cameco Where Cameco stock closed and what
CRISPR Therapeutics AG (CRSP) Stock: ARK Invest Adds Shares as Wall Street Weighs Zugo‑cel Data, Insider Sale, and 2026 Catalysts

CRISPR Therapeutics AG (CRSP) Stock: ARK Invest Adds Shares as Wall Street Weighs Zugo‑cel Data, Insider Sale, and 2026 Catalysts

NEW YORK, Dec. 27, 2025, 4:58 p.m. ET — Market closed (U.S. equities are shut for the weekend) CRISPR Therapeutics AG (NASDAQ: CRSP) heads into the final trading stretch of 2025 with investors balancing two forces that often define biotech stocks: headline-driven momentum and long-duration fundamental risk. The stock finished the most recent regular session (Friday, Dec. 26) at $55.08, down 2.87%, after trading between $56.54 and $53.76. In after-hours trading, CRSP was last shown around $55.24 late Friday evening. StockAnalysis That Friday move came against a holiday-thinned tape on Wall Street. Reuters described the broader market session as light-volume

Stock Market Today

Corning stock price hits record close — what’s driving GLW and the next big test

Corning stock price hits record close — what’s driving GLW and the next big test

7 February 2026
Corning shares jumped 8.3% to a record $122.16 Friday, gaining 11% over two sessions amid strong demand for AI infrastructure stocks. The move follows a $6 billion optical fiber deal with Meta and upgraded company forecasts. Shares traded as high as $122.56 and rose 0.6% after hours. COO Avery Nelson sold 1,894 shares for tax withholding, retaining 66,050.
PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

PepsiCo stock: €2.5 billion bond deal lands as investors size up the price-cut gamble

7 February 2026
PepsiCo priced €2.5 billion in euro notes across four maturities, with settlement set for Feb. 11, according to an SEC filing. The company plans to use proceeds for general corporate purposes, including repaying commercial paper. Shares closed at $170.49 Friday, up 1.8%. PepsiCo is also cutting U.S. snack prices by up to 15% after consumer pushback.
Go toTop